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Asthmatic horses were inadvertently removed from the study, and some of the corrected values including those related to the sensitivity and specificity of the tests were not included in the article. Also, Table [2](#jvim15595-tbl-0001){ref-type="table"}, Figure 2 and Figure 3 need modification. In most cases, the new values are similar to that reported in the published article and they do not change the discussion and conclusions from the study.

###### 

Sensitivity and specificity for all biomarkers and combination. Sensitivity and specificity were calculated using 14 neutrophilic asthmatic horses, 9 healthy controls and 10 pathologic controls. HOARSI, Horse Owner Assessed Respiratory Signs Index; SP‐D, Surfactant protein D; Se, sensitivity; Sp, specificity

  Criteria                                                                               Sensitivity (%)   Specificity (%)
  -------------------------------------------------------------------------------------- ----------------- -----------------
  SP‐D \> 58,9 ng/mL                                                                     57                84
  SP‐D \> 58,9 ng/mL and HOARSI = 2                                                      57                100
  Haptoglobin \>6347 ng/mL                                                               79                41
  Haptoglobin \>6347 ng/mL and HOARSI = 2                                                71                100
  SCGB \<25,7 ng/mL                                                                      77                47
  SCGB \<25,7 ng/mL and HOARSI = 2                                                       79                100
  SP‐D \> 58,9 ng/mL and Haptoglobin \>6347 ng/mL                                        50                95
  SP‐D \> 58,9 ng/mL and Haptoglobin \>6347 ng/mL and HOARSI = 2                         50                100
  SP‐D \> 58,9 ng/mL and SCGB \<25,7 ng/mL                                               50                95
  SP‐D \> 58,9 ng/mL and SCGB \<25,7 ng/mL and HOARSI = 2                                50                100
  Haptoglobin \>6347 ng/mL and SCGB \<25,7 ng/mL                                         64                63
  Haptoglobin \>6347 ng/mL and SCGB \<25,7 ng/mL and HOARSI = 2                          64                100
  SP‐D \> 58,9 ng/mL and Haptoglobin \>6347 ng/mL and SCGB \<25,7 ng/mL                  57                100
  SP‐D \> 58,9 ng/mL and Haptoglobin \>6347 ng/mL and SCGB \<25,7 ng/mL and HOARSI = 2   57                100

The corrections are as follows.

**Abstract, Results section**

**Results**

Serum concentration of SP‐D \> 58.9 ng/mL, serum concentration of haptoglobin \>6347 ng/mL and serum concentration of SCGB \<25.7 ng/mL allowed differentiation of horses with neutrophilic asthma from horses of the control groups (healthy and pathologic) with sensitivity of 57, 79 and 77%, and specificity of 84, 41 and 47, respectively. Specificity of 100% and sensitivity of 57% were obtained with the combination of SP‐D, haptoglobin, and SCGB at the serum concentrations indicated above. Specificity of 95% and sensitivity of 50% were obtained with the combination of SP‐D and SCGB serum concentrations.

**3 STATISTICS section, paragraph 1, sentence 5**

Tukey\'s post‐tests rather than Turkey\'s post‐tests were used.

**4.5 Blood biomarkers section, paragraphs 2, 3 and 4**

A cutoff of 58.9 ng/mL for SP‐D allowed differentiation of horses with neutrophilic asthma from controls (healthy and pathologic) with sensitivity and specificity of 57% and 84%, respectively, and the area under the curve (AUC) was 0.75 (95% confidence interval \[Cl\], 0.57‐0.93; *P* = .015; Figure 3 and Table [2](#jvim15595-tbl-0001){ref-type="table"}). Horses with haptoglobin concentration \> 6347 ng/mL were more likely to have neutrophilic asthma with sensitivity and specificity of 79% and 41%, respectively, and the AUC was 0.6 (95% Cl, 0.40‐0.81; *P* = .3). Horses with SCGB concentration \< 25.7 ng/mL were more likely to have neutrophilic asthma, with sensitivity of 77% and specificity of 47% and the AUC was 0.68 (95% Cl, 0.47‐0.89; *P* = .09).

Sensitivity of 57% and specificity of 100% were obtained with the combination of SP‐D \> 58.9 ng/mL, haptoglobin \>6347 ng/mL and SCGB \<25.7 ng/mL (Table [2](#jvim15595-tbl-0001){ref-type="table"}) for the diagnosis of neutrophilic asthma (AUC, 0.6; 95% Cl, 0.41‐0.80; *P* = .3). Sensitivity of 50% and specificity of 95% were obtained with the combination of SP‐D \> 58.9 ng/mL and SCGB \<25.7 ng/mL (AUC, 0.69; 95% Cl, 0.49‐0.89; *P* = .07).

Specificity of the biomarker combinations all were increased with inclusion of the criterion HOARSI = 2 (Table [2](#jvim15595-tbl-0001){ref-type="table"}). The combination of SP‐D \> 58.9 ng/mL, and haptoglobin \>6347 ng/mL or the combination of SP‐D \> 58.9 ng/mL and SCGB \<25.7 ng/mL showed sensitivity of 50% and specificity of 100%. Haptoglobin \>6347 ng/mL or SCGB \<25.7 ng/mL had sensitivity of 71 and 79%, and specificity of 100 and 100%, respectively.

**5 Discussion section, paragraph 3, sentence 10**

These biomarkers only showed a sensitivity of 50% and specificity of 95% when combined in our population of horses.

Figure 2 Serum concentration of surfactant protein D (SP‐D) (A), haptoglobin (B), and SCGB (C) in horses with neutrophilic asthma (n = 14) and controls (healthy \[n = 9\] and pathologic \[n = 10\]). Values were log transformed for analysis. Figure 2A P value should be *P* = .03 rather than *P* = .003. Figure 2B Corrected for the number of dots and its legend. Serum concentration values of haptoglobin were lacking for 1 healthy control and 1 pathologic control. The number of dots is now in accordance with the information in the text. Figure 2C Corrected for the number of dots, in accordance with text\'s information.
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Figure 3 Receiver operating characteristic curves of the biomarkers surfactant protein D (SP‐D) (A), haptoglobin (B), and SCGB (C) Figure 3A, B and C.

Receiver operating characteristic curves of the biomarkers SP‐D (A), haptoglobin (B) and SCGB (C) need to be changed.
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